Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XShares Advisors was a financial services firm that specialized in the development and management of exchange-traded funds (ETFs) with a primary focus on the healthcare and life sciences sectors. The company is best known for its 'HealthShares' series, which consisted of over 20 ETFs designed to provide targeted exposure to specific therapeutic areas such as cardiology, neuroscience, dermatology, and infectious diseases. Unlike broad healthcare indices, XShares utilized a vertically integrated indexing approach to capture niche segments of the biotechnology and medical device markets. Although the firm was a pioneer in thematic healthcare investing, most of its HealthShares ETFs were liquidated or delisted by 2010 due to low trading volumes and the impact of the global financial crisis. In 2014, the company's assets and management platform were acquired by WBI Investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XShares Advisors.